Smallwood L, Allcock R, van Bockxmeer F, Warrington N, Palmer L J, Iacopetta B, Norman P E
School of Surgery and Pathology, University of Western Australia.
Eur J Vasc Endovasc Surg. 2008 Jan;35(1):31-6. doi: 10.1016/j.ejvs.2007.08.021. Epub 2007 Nov 8.
Elevated levels of circulating interleukin-6 (IL-6) have been reported in patients with abdominal aortic aneurysms (AAAs). Although this implicates inflammation as a cause of AAAs, there is also evidence that the aneurysmal aorta may secrete IL-6 into the circulation as a result of aortic proteolysis. Genetic association studies are one means of trying to clarify the role of specific mediators in the causal pathway. The aim of the present study was to examine the association between variants of the IL-6 gene and AAAs.
An association study involving 677 men with screen-detected AAAs and 656 age-matched controls was performed. Three variants in the IL-6 promoter region were analysed: IL-6-174G>C (rs1800795), IL-6-572G>C (rs1800796) and IL-6-597G>A (rs1800797). Univariate regression of SNP genotype on AAA as a binary outcome was initially performed under a range of genetic models (additive, dominant and recessive). This was followed by multivariate analyses, testing the same models but including risk factors known to be associated with AAAs. All analyses and haplotype estimation were performed under a generalized linear model framework.
IL-6-572G>C polymorphism (frequency 1.5% in cases) was identified as an independent risk factor for AAA with an odds ratio (OR) of 6.00 (95%CI: 1.22, 29.41) when applied to the recessive model. No association was seen in the additive or dominant models. In a multivariate analysis using the most common haplotype (h.111, frequency 48.7%) as a reference, h.211 (frequency 4.4%) was an independent risk factor for AAA (OR 1.56, 95%CI: 1.02, 2.39).
The IL-6 572G>C polymorphism (and h.211 haplotype) is associated with AAA, however it is too rare to be an important cause of most AAAs. This does not support the concept that the elevated level of IL-6 reported in patients with AAAs is a primary cause of the aneurysmal process.
据报道,腹主动脉瘤(AAA)患者循环中的白细胞介素-6(IL-6)水平升高。虽然这表明炎症是AAA的一个病因,但也有证据表明,由于主动脉蛋白水解,动脉瘤样主动脉可能会将IL-6分泌到循环中。基因关联研究是试图阐明特定介质在因果途径中作用的一种方法。本研究的目的是检查IL-6基因变异与AAA之间的关联。
进行了一项关联研究,纳入677名经筛查发现患有AAA的男性和656名年龄匹配的对照。分析了IL-6启动子区域的三个变异:IL-6-174G>C(rs1800795)、IL-6-572G>C(rs1800796)和IL-6-597G>A(rs1800797)。最初在一系列遗传模型(加性、显性和隐性)下,将SNP基因型对AAA作为二元结局进行单变量回归分析。随后进行多变量分析,测试相同的模型,但纳入已知与AAA相关的危险因素。所有分析和单倍型估计均在广义线性模型框架下进行。
IL-6-572G>C多态性(病例中频率为1.5%)被确定为AAA的独立危险因素,应用隐性模型时比值比(OR)为6.00(95%CI:1.22,29.41)。在加性或显性模型中未发现关联。在以最常见单倍型(h.111,频率48.7%)为参照的多变量分析中,h.211(频率4.4%)是AAA的独立危险因素(OR 1.56,95%CI:1.02,2.39)。
IL-6 572G>C多态性(和h.211单倍型)与AAA相关,然而其过于罕见,并非大多数AAA的重要病因。这并不支持AAA患者中报道的IL-6水平升高是动脉瘤形成过程主要原因的观点。